Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32093| Title: | Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. | Austin Authors: | Wines, Bruce D;Kurtovic, Liriye;Trist, Halina M;Esparon, Sandra;Lopez, Ester;Chappin, Klasina;Chan, Li-Jin;Mordant, Francesca L;Lee, Wen Shi;Gherardin, Nicholas A;Patel, Sheila K ;Hartley, Gemma E;Pymm, Phillip;Cooney, James P;Beeson, James G;Godfrey, Dale I;Burrell, Louise M ;van Zelm, Menno C;Wheatley, Adam K;Chung, Amy W;Tham, Wai-Hong;Subbarao, Kanta;Kent, Stephen J;Hogarth, P Mark | Affiliation: | Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia. Life Sciences, Burnet Institute, Melbourne, VIC, Australia. Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia. Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia. Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia. Medicine (University of Melbourne) Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia. Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. Life Sciences, Burnet Institute, Melbourne, VIC, Australia. Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia. Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia. |
Issue Date: | 2022 | Date: | 2023 | Publication information: | Frontiers in Immunology 2022; 13 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32093 | DOI: | 10.3389/fimmu.2022.1122516 | ORCID: | Journal: | Frontiers in Immunology | Start page: | 1122516 | PubMed URL: | 36703991 | ISSN: | 1664-3224 | Type: | Journal Article | Subjects: | ACE2-Fc ADCC COVID-19 SARS-CoV-2 antibody effector function complement coronavirus neutralization |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.